The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.

Date publication

novembre 2023

Journal

Influenza and other respiratory viruses

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DABAKUYO-YONLI Sandrine , Dr BILLA Oumar , Dr MAMGUEM KAMGA Ariane

Tous les auteurs :
Ouedraogo S, Traoré IT, Kania D, Kaboré NF, Mamguem Kamga A, Badolo H, Yara M, Sanou G, Koné A, Kagoné ST, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendere AE, Ouédraogo B, Billa O, Paradis G, Tinto H, Dabakuyo-Yonli TS

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38019697

Résumé

This study aimed to estimate the anti-SARS-CoV-2 antibody seroprevalence in the general population of Bobo-Dioulasso and Ouagadougou (Burkina Faso).

Mots clés

Burkina Faso, COVID-19, SARS-CoV-2, WHO UNITY study, infectious disease, population-based seroprevalence

Référence

Influenza Other Respir Viruses. 2023 11;17(11):e13216